Title | Type I interferon exacerbates Mycobacterium tuberculosis induced human macrophage death. |
Publication Type | Journal Article |
Year of Publication | 2024 |
Authors | Lee AM, Nathan CF |
Journal | EMBO Rep |
Volume | 25 |
Issue | 7 |
Pagination | 3064-3089 |
Date Published | 2024 Jul |
ISSN | 1469-3178 |
Keywords | Animals, Cell Death, Cells, Cultured, Humans, Interferon Type I, Macrophages, Mice, Mycobacterium tuberculosis, Signal Transduction, Tuberculosis |
Abstract | Type I interferons (IFN-I) are implicated in exacerbation of tuberculosis (TB), but the mechanisms are unclear. Mouse macrophages infected with Mycobacterium tuberculosis (Mtb) produce IFN-I, which contributes to their death. Here we investigate whether the same is true for human monocyte-derived macrophages (MDM). MDM prepared by a conventional method markedly upregulate interferon-stimulated genes (ISGs) upon Mtb infection, while MDM prepared to better restrict Mtb do so much less. A mixture of antibodies inhibiting IFN-I signaling prevents ISG induction. Surprisingly, secreted IFN-I are undetectable until nearly two days after ISG induction. These same antibodies do not diminish Mtb-infected MDM death. MDM induce ISGs in response to picogram/mL levels of exogenous IFN-I while depleting similar quantities from the medium. Exogenous IFN-I increase the proportion of dead MDM. We speculate that Mtb-infected MDM produce and respond to minute levels of IFN-I, and that only some of the resultant signaling is susceptible to neutralizing antibodies. Many types of cells may secrete IFN-I in patients with TB, where IFN-I is likely to promote the death of infected macrophages. |
DOI | 10.1038/s44319-024-00171-0 |
Alternate Journal | EMBO Rep |
PubMed ID | 38866980 |
PubMed Central ID | PMC11239827 |
Grant List | R01 AI138940 / AI / NIAID NIH HHS / United States RO1 AI138940 / / HHS | National Institutes of Health (NIH) / |
Submitted by ljc4002 on August 21, 2025 - 1:54pm